Evolutionary Genomics, Inc.
FNAM
$0.0002
-$0.0006-75.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -1.94M | -2.27M | -2.78M | -2.81M | -2.79M |
| Total Depreciation and Amortization | 1.02M | 1.03M | 1.03M | 1.03M | 1.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 193.30K | 267.80K | 161.10K | 137.80K | 136.20K |
| Change in Net Operating Assets | 79.30K | 131.50K | -20.60K | 68.50K | 35.60K |
| Cash from Operations | -640.90K | -843.90K | -1.61M | -1.56M | -1.58M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 1.50M | 1.50M | 1.58M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 550.00K | 550.00K | 550.00K | 550.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 454.00K | 454.00K | 454.00K | 454.00K | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.00M | 1.00M | 2.51M | 2.51M | 1.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 363.10K | 160.10K | 897.20K | 944.70K | -1.90K |